Who would most benefit from improved integrated care? Implementing an analytical strategy in South Somerset

Por Kasteridis, Panagiotis, Street, Andrew, Dolman, Matthew, Gallier, Lesley, Hudson, Kevin, Martin, Jeremy, Wyer, Ian
Publicado no Int J Integr Care (2015)

A Generic Platform for Cellular Screening Against Ubiquitin Ligases

Por Maculins, Timurs, Carter, Nikki, Dorval, Thierry, Hudson, Kevin, Nissink, J. Willem M., Hay, Ronald T., Alwan, Husam
Publicado no Sci Rep (2016)

The use of (18)F-Fluoro-deoxy-glucose positron emission tomography ((18)F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active d...

Por Maynard, Juliana, Emmas, Sally-Ann, Ble, Francois-Xavier, Barjat, Herve, Lawrie, Emily, Hancox, Urs, Polanska, Urszula M., Pritchard, Alison, Hudson, Kevin
Publicado no PLoS One (2017)

Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer

Por Avivar-Valderas, Alvaro, McEwen, Robert, Taheri-Ghahfarokhi, Amir, Carnevalli, Larissa S., Hardaker, Elizabeth L., Maresca, Marcello, Hudson, Kevin, Harrington, Elizabeth A., Cruzalegui, Francisco
Publicado no Oncotarget (2018)

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome

Por Ashford, Anne L., Dunkley, Tom P. J., Cockerill, Mark, Rowlinson, Rachel A., Baak, Lisa M., Gallo, Raffaella, Balmanno, Kathryn, Goodwin, Louise M., Ward, Richard A., Lochhead, Pamela A., Guichard, Sylvie, Hudson, Kevin, Cook, Simon J.
Publicado no Cell Mol Life Sci (2015)

PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8(+) T-cell activity

Por Carnevalli, Larissa S., Sinclair, Charles, Taylor, Molly A., Gutierrez, Pablo Morentin, Langdon, Sophie, Coenen-Stass, Anna M. L., Mooney, Lorraine, Hughes, Adina, Jarvis, Laura, Staniszewska, Anna, Crafter, Claire, Sidders, Ben, Hardaker, Elizabeth, Hudson, Kevin, Barry, Simon T.
Publicado no J Immunother Cancer (2018)

Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients

Por Guinney, Justin, Ferté, Charles, Dry, Jonathan, McEwen, Robert, Manceau, Gilles, Kao, KJ, Chang, Kai-Ming, Bendtsen, Claus, Hudson, Kevin, Huang, Erich, Dougherty, Brian, Ducreux, Michel, Soria, Jean-Charles, Friend, Stephen, Derry, Jonathan, Laurent-Puig, Pierre
Publicado em 2013